These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

433 related items for PubMed ID: 22617249

  • 21. New syngeneic inflammatory-related lung cancer metastatic model harboring double KRAS/WWOX alterations.
    Bleau AM, Freire J, Pajares MJ, Zudaire I, Anton I, Nistal-Villán E, Redrado M, Zandueta CN, Garmendia I, Ajona D, Blanco D, Pio R, Lecanda F, Calvo A, Montuenga LM.
    Int J Cancer; 2014 Dec 01; 135(11):2516-27. PubMed ID: 24473991
    [Abstract] [Full Text] [Related]

  • 22. Cytoplasmic Ape1 expression elevated by p53 aberration may predict survival and relapse in resected non-small cell lung cancer.
    Wu HH, Chu YC, Wang L, Tsai LH, Lee MC, Chen CY, Shieh SH, Cheng YW, Lee H.
    Ann Surg Oncol; 2013 Dec 01; 20 Suppl 3():S336-47. PubMed ID: 22688662
    [Abstract] [Full Text] [Related]

  • 23. Aldehyde dehydrogenase activity selects for lung adenocarcinoma stem cells dependent on notch signaling.
    Sullivan JP, Spinola M, Dodge M, Raso MG, Behrens C, Gao B, Schuster K, Shao C, Larsen JE, Sullivan LA, Honorio S, Xie Y, Scaglioni PP, DiMaio JM, Gazdar AF, Shay JW, Wistuba II, Minna JD.
    Cancer Res; 2010 Dec 01; 70(23):9937-48. PubMed ID: 21118965
    [Abstract] [Full Text] [Related]

  • 24. Pathobiological implications of MUC4 in non-small-cell lung cancer.
    Majhi PD, Lakshmanan I, Ponnusamy MP, Jain M, Das S, Kaur S, Shimizu ST, West WW, Johansson SL, Smith LM, Yu F, Rolle CE, Sharma P, Carey GB, Batra SK, Ganti AK.
    J Thorac Oncol; 2013 Apr 01; 8(4):398-407. PubMed ID: 23370366
    [Abstract] [Full Text] [Related]

  • 25. CXCR4 promotes cisplatin-resistance of non-small cell lung cancer in a CYP1B1-dependent manner.
    Xie S, Tu Z, Xiong J, Kang G, Zhao L, Hu W, Tan H, Tembo KM, Ding Q, Deng X, Huang J, Zhang Q.
    Oncol Rep; 2017 Feb 01; 37(2):921-928. PubMed ID: 27922681
    [Abstract] [Full Text] [Related]

  • 26. Decrease of PDSS2 expression, a novel tumor suppressor, in non-small cell lung cancer.
    Chen P, Yu J, Knecht J, Chen Q.
    Cancer Epidemiol; 2013 Apr 01; 37(2):166-71. PubMed ID: 23312889
    [Abstract] [Full Text] [Related]

  • 27. Ornithine decarboxylase mRNA expression in curatively resected non-small-cell lung cancer.
    Grimminger PP, Schneider PM, Metzger R, Vallböhmer D, Danenberg KD, Danenberg PV, Hölscher AH, Brabender J.
    Clin Lung Cancer; 2010 Mar 01; 11(2):114-9. PubMed ID: 20199977
    [Abstract] [Full Text] [Related]

  • 28. Frequent down-regulation of pim-1 mRNA expression in non-small cell lung cancer is associated with lymph node metastases.
    Warnecke-Eberz U, Bollschweiler E, Drebber U, Pohl A, Baldus SE, Hoelscher AH, Metzger R.
    Oncol Rep; 2008 Sep 01; 20(3):619-24. PubMed ID: 18695914
    [Abstract] [Full Text] [Related]

  • 29. High TBX2 expression predicts poor prognosis in non-small cell lung cancer.
    Zhang Z, Guo Y.
    Neoplasma; 2014 Sep 01; 61(4):476-80. PubMed ID: 25027744
    [Abstract] [Full Text] [Related]

  • 30. Apelin expression in human non-small cell lung cancer: role in angiogenesis and prognosis.
    Berta J, Kenessey I, Dobos J, Tovari J, Klepetko W, Jan Ankersmit H, Hegedus B, Renyi-Vamos F, Varga J, Lorincz Z, Paku S, Ostoros G, Rozsas A, Timar J, Dome B.
    J Thorac Oncol; 2010 Aug 01; 5(8):1120-9. PubMed ID: 20581707
    [Abstract] [Full Text] [Related]

  • 31. RBX1 expression is an unfavorable prognostic factor in patients with non-small cell lung cancer.
    Xing R, Chen KB, Xuan Y, Feng C, Xue M, Zeng YC.
    Surg Oncol; 2016 Sep 01; 25(3):147-51. PubMed ID: 27566015
    [Abstract] [Full Text] [Related]

  • 32. Clinical implications of microsomal prostaglandin e synthase-1 overexpression in human non-small-cell lung cancer.
    Wang HW, Hsueh CT, Lin CF, Chou TY, Hsu WH, Wang LS, Wu YC.
    Ann Surg Oncol; 2006 Sep 01; 13(9):1224-34. PubMed ID: 16952028
    [Abstract] [Full Text] [Related]

  • 33. [Nuclear factor-kappaB activity and its correlation with cell proliferation in non-small cell lung cancer tissues].
    Zhang J, Xu YJ, Zhang ZX, DU CL, Qiao LF, Ni W, Chen SX.
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Oct 01; 30(10):771-5. PubMed ID: 18218209
    [Abstract] [Full Text] [Related]

  • 34. Depleted aldehyde dehydrogenase 1A1 (ALDH1A1) reverses cisplatin resistance of human lung adenocarcinoma cell A549/DDP.
    Wei Y, Wu S, Xu W, Liang Y, Li Y, Zhao W, Wu J.
    Thorac Cancer; 2017 Jan 01; 8(1):26-32. PubMed ID: 27813328
    [Abstract] [Full Text] [Related]

  • 35. A CD90(+) tumor-initiating cell population with an aggressive signature and metastatic capacity in esophageal cancer.
    Tang KH, Dai YD, Tong M, Chan YP, Kwan PS, Fu L, Qin YR, Tsao SW, Lung HL, Lung ML, Tong DK, Law S, Chan KW, Ma S, Guan XY.
    Cancer Res; 2013 Apr 01; 73(7):2322-32. PubMed ID: 23382045
    [Abstract] [Full Text] [Related]

  • 36. Total cyclooxygenase-2 mRNA levels correlate with vascular endothelial growth factor mRNA levels, tumor angiogenesis and prognosis in non-small cell lung cancer patients.
    Yuan A, Yu CJ, Shun CT, Luh KT, Kuo SH, Lee YC, Yang PC.
    Int J Cancer; 2005 Jul 01; 115(4):545-55. PubMed ID: 15704107
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. CIP2A is overexpressed in non-small cell lung cancer and correlates with poor prognosis.
    Dong QZ, Wang Y, Dong XJ, Li ZX, Tang ZP, Cui QZ, Wang EH.
    Ann Surg Oncol; 2011 Mar 01; 18(3):857-65. PubMed ID: 20842459
    [Abstract] [Full Text] [Related]

  • 40. High expression levels of MAGE-A9 are correlated with unfavorable survival in lung adenocarcinoma.
    Zhai X, Xu L, Zhang S, Zhu H, Mao G, Huang J.
    Oncotarget; 2016 Jan 26; 7(4):4871-81. PubMed ID: 26717042
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.